510(k) Report

De Novo · Granted

Granted

LightStrike+ (MXSUV1-SL and MXSUV1-FT)

DEN230007De NovoGranted Sep 1, 2023212-day reviewClass II21 CFR 880.6510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Xenex Disinfection Services, Inc. · QXJ Whole Room Microbial Reduction Device

Granted on Sep 1, 2023 as a new device type through De Novo after a 212-day review. 1 later device descends from it.

Decided
Sep 1, 2023
Review
212 days
Class
Class II
Product code
QXJ
Recalls
None

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2025: 1 descendant cleared2020202220242026
  1. This deviceDEN230007 LightStrike+ (MXSUV1-SL and MXSUV1-FT)Xenex Disinfection Services, Inc. · 2023
  2. Descendant · cites it directly · 0 of its ownK242604 Helios+ UV-C SystemPreventamed Technologies, Inc. Dba Surfacide Manufacturing · 2025

Most influential descendants

Showing 1 of 1 · See all
  • K242604Helios+ UV-C SystemPreventamed Technologies, Inc. Dba Surfacide Manufacturing · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)DEN230007LightStrike+ (MXSUV1-SL and MXSUV1-FT)Xenex Disinfection Services, Inc.2023—
+1K242604Helios+ UV-C SystemPreventamed Technologies, Inc. Dba Surfacide Manufacturing2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
FIG. 1 — Lineage of DEN230007, 2023–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA De Novo database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QXJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QXJ device

  1. #1 K242604 Helios+ UV-C Systemscore 9.4 · 1 generation · no Class I recall
Get a 510(k) Report

Does it have a predicate?

De Novo decisions do not claim a predicate device.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K242604Helios+ UV-C SystemPreventamed Technologies, Inc. Dba Surfacide Manufacturing20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K242604 (Preventamed Technologies, Inc. Dba Surfacide Manufacturing, 2025) has gone furthest, with 0 descendants of its own.

How does its category compare?

All QXJ devices

QXJ Whole Room Microbial Reduction Device: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · QXJ

1in 2025

2023: 12025: 1
2007high 1 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QXJ

Too few QXJ 510(k)s in any year since 2007 to give a median.

Recalls per year · QXJ

No recall names QXJ since 2007.

Adverse event reports per year · QXJ

1in 2025

2025: 1
2007high 1 (2025) · low 0 (2007)2025

MAUDE reports naming product code QXJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20231—00
20240—00
20251—01
20260—0—

What is it indicated for?

The Xenex LightStrike™+ is a pulsed, broad-spectrum, high-intensity, germicidal UV light system intended to perform microbial reduction on non-porous, non-critical medical device surfaces, free from visual soiling, after manual cleaning and disinfection practices. LightStrike+ is intended for use in unoccupied operating rooms, hospital rooms, and other clinical settings where non-critical medical devices are present as an adjunct to existing manual cleaning and disinfection practices. The system is for over-the-counter (OTC) use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “DEN230007: LightStrike+ (MXSUV1-SL and MXSUV1-FT).” Lineage record from FDA De Novo data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/DEN230007

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026